MarketReports.com
 
 
Agriculture
Automotive & Transport
Business & Finance
Consumer & Retail
Energy & Environment
Government & Public Sector
Manufacturing, Construction and Engineering
Pharmaceuticals & Healthcare
Technology & Media





Instrumentation & Equipment

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Instrumentation & Equipment

Mass Spectrometry 2013: A Focus on Sales Growth



Price



Publication Date: 04-Feb-2013
Pages: 262
Publisher: Biopharm Reports

Mass Spectrometry 2013 presents the findings of a global market study of mass spectrometry, involving the participation of 567 buyers and end-users in this field. With a focus on market development, sales growth and commercial opportunities, the study profiled current and evolving areas of this market, as outlined below. Its findings provide valuable product and market information, and decision-making support to suppliers in the mass spectrometry field.

More
Mass Spectrometry 2012: A Focus on Sales Growth



Price



Publication Date: 15-August-2012
Pages: 262
Publisher: Biopharm Reports

Background

The market for MS instrumentation has grown rapidly over the past decade and in 2009 global sales and ancillary services were approximately $3.3 billion and continuing to grow at around 10% per year. However markets are also changing as new applications are developed and new instruments are launched. Today, more than ever, developers and vendors in the MS field are targeting their resources in those areas that best support their own sales and growth strategies.

Purpose

This report, based on an analysis of prevailing and emerging market conditions in the MS field, has been produced to assist marketing and sales, and the identification of new opportunities. It is the outcome of an extensive global study involving 567 experienced MS users. It's findings provide a “focus on sales growth” to developers and vendors in the MS field, and the changes that are driving these developments.

Analysis

As part of this report, market areas outlined below have been analysed to provide information relevant to marketing and sales, new market opportunities, qualified sales leads, customer needs and future plans, competitive position, new and emerging applications, growing and declining areas and threats.

Market Areas

· Companies: Purchases of MS instruments and related systems from MS companies and anticipated purchases from specific mass spectrometry companies over the next three years, ranked according to prominence.
· Ionisation Methods: Current use of more than 30 ionisation methods and the anticipated use of ionisation methods over the next three years, ranked according to prominence.
· Ion Analysers: Current use of more than 30 ion analysers and the anticipated use of ion analysers over the next three years, ranked according to prominence.
· MS Configurations: Current use of more than 100 MS configurations and the anticipated use of MS configurations over the next three years, ranked according to prominence.
· Fragmentation Methods: Current use of more than 20 fragmentation methods and the anticipated use of fragmentation methods over the next three years, ranked according to prominence.
· Innovation: Greatest areas of innovation in the MS field that are anticipated over the next three years relating to ionisation methods, ion analysers, detection methods, data systems/specialist software, sample preparation and other areas; most needed areas of innovation in the MS field over the next three years relating to ionisation methods, ion analysers, detection methods, data systems/specialist software, sample preparation and other areas; most important innovations in the mass spectrometry field over the last three years and the most important emerging applications in the MS field, over the next three years.
· Challenging Applications: Disclosures on 250+ analyte molecule types that present particular challenges or problems to MS analysis, ranked according to prominence; 115+ sample matrices associated with samples that present particular problems to MS analysis, ranked according to prominence; ionisation methods, ion analysers, MS configurations, fragmentation methods and sample preparation techniques that are used for molecule types that present particular challenges to mass spectrometric analysis, ranked according to prominence and underlying reasons associated with their most challenging mass spectrometry applications, grouped and ranked according to prominence.
· Expenditure: Average hourly, daily and annual running costs per MS system; average annual budgets relating to the use of mass spectrometry; the breakdown of financial budgets relating to MS instruments, sample preparation instruments, consumables, data handling/specialist software and other areas; anticipated budgets over the next three years and the top three consumables in the MS field, in terms of cost.
· Data Systems: Current use of integrated data systems (supplied with the MS systems purchased) or alternatively, the use of independent data systems; current use of more than 30 independent data systems, ranked according to their level of use; current use of more than 80 database software systems, ranked according to their level of use and the use of database software over the next three years, ranked according to their anticipated level of use.
· Mass Spectrometry Activities: Time expenditure on the part of MS users, relating to data handling, sample preparation and mass spectrometric analysis.
· Participant Fields: Biotechnology, chemicals, clinical, defence, energy, environmental, food and drink, forensics, geology, healthcare, natural products, pharmaceuticals, universities and research institutes.
· Purpose: Purpose or reason for carrying out mass spectrometry across 13 major fields previously indicated, profiled and ranked according to prominence.
· Study Samples: Study samples analysed across 13 fields previously indicated, each ranked according to prominence.
· Analyte Molecules: Analyte molecule classes analysed using MS across 13 fields previously indicated, each ranked according to prominence.
· Applications: MS applications across 13 fields previously indicated, each profiled and ranked according to prominence.
· Sample Preparation: Current use of sample preparation methods and the anticipated use of sample preparation methods over the next three years, ranked according to prominence.
· Quantitative vs. Qualitative: The percentage of current MS applications that are either quantitative, qualitative or both.



Table of Contents
Ablation Technologies Market (2011-2016) - (Cancer/tumor, Cardiac, Gynecology, Orthopedics, Radiofrequency, Cryoablation, Microwave, Hydrothermal, Radiation and Laser/ Light) - Global Trends & Competitive Analysis



Price



Publication Date: May-2012
Format: PDF
Pages: 350
Publisher: MarketsandMarkets
Table of Contents

The global ablation technologies market consists of thermal and non- thermal ablation technologies. Under thermal ablation technologies, radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies are included, whereas non-thermal ablation technologies include cryoablation and hydromechanical. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics. Global ablation technologies market was valued at $7.5 billion in 2011 and is poised to grow at a CAGR of 10.5% to reach $12.4 billion by 2016.

More...
Life Science and Chemical Instrumentation Market (2011 - 2016) (Spectroscopy, Chromatography, DNA Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others)



Price



Publication Date: Feb-2012
Format: PDF
Pages: 391
Publisher: MarketsandMarkets
Table of Contents

Life science and chemical instruments are used extensively in research and development activities, laboratories being one of the major users. Use of life science and chemical instruments for disease diagnosis is on a rise; for example, flow cytometers are used for diagnosis of all four types of leukemia.

Life science and chemical equipment market is growing at a rapid rate due to the continuous requirement of these instruments in pharmaceutical and biotechnology industries. Besides, the increase in number of biotechnology firms worldwide, advances in life science research and technology innovations with human genome mapping, and emergence of proteomics have enabled industry growth; as such high-end research projects require quality instruments with high throughput capacity. All these factors are driving the life science and chemical instrumentation market.

More...
Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)



Price



Publication Date: Aug-2011
Format: PDF
Pages: 278
Publisher: MarketsandMarkets
Table of Contents

A biochip is defined as a collection of miniaturized test sites (microarrays) arranged on a solid platform that allows multiple tests to be performed at the same time with increased efficiency and higher speed. The global biochip market is studied by the types and key applications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 billion by 2015; growing at a CAGR of 16.7%. This growth is attributed to increasing applications in cancer diagnostics and expression profiling, the boom in personalized medicine, and government funding.

More...
Global DNA & Gene Chip (Microarray) Market (2010 - 2015)



Price



Publication Date: May-2011
Format: PDF
Pages: 331
Publisher: MarketsandMarkets
Table of Contents

Microarrays were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence has seen an influx of players vying fiercely for a share or this market. The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.
Gene Expression currently forms the largest application market as gene expression products are used in a wide variety of research activities including life sciences research, clinical diagnostics, biodefense, and agriculture. While this application contributed 28% to the Global DNA & Gene Chip (microarray) market revenues in 2010, cancer diagnosis and treatment application is expected to dominate the applications market by 2015; accounting for about 24% share in the market.

More...

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Instrumentation & Equipment